Anifrolumab Pregnancy Study

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

NCT04726553 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus

NCT00004663 ·Status: COMPLETED

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

NCT02547922 ·Status: COMPLETED ·Phase: PHASE2

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

NCT02103361 ·Status: RECRUITING

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

NCT00198068 ·Status: RECRUITING

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

NCT05835310 ·Status: RECRUITING ·Phase: PHASE3

Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)

NCT05001698 ·Status: COMPLETED ·Phase: PHASE1

Study on the Safety for the Newborn of the Use of Biologics During Pregnancy by Mothers Affected by Autoimmune Diseases

NCT04197232 ·Status: RECRUITING

A Study of DS-7011a in Patients With Systemic Lupus Erythematosus

NCT05638802 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT05138133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

NCT02962960 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446899 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

NCT04963296 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome

NCT05176041 ·Status: COMPLETED

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

NCT00712933 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446912 ·Status: COMPLETED ·Phase: PHASE3

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

NCT05440422 ·Status: RECRUITING ·Phase: PHASE2

A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

NCT06015737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)

NCT03556007 ·Status: COMPLETED ·Phase: PHASE1

An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults

NCT01753193 ·Status: COMPLETED ·Phase: PHASE2

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus

NCT00004662 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

NCT04976322 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

NCT05203692 ·Status: COMPLETED ·Phase: PHASE1

Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

NCT06046534 ·Status: COMPLETED

Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02794285 ·Status: COMPLETED ·Phase: PHASE3